BIOMAT Database Logo BIOMAT Database Logo

Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study. 1979

T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin

Nineteen patients with acute psychoses, the majority schizophrenics, were studied in the course of chlorpromazine (CPZ) treatment. Plasma levels of the drug, plasma prolactin (PRL), extrapyramidal side-effects (EPS) and changes in mental state were monitored weekly, as in our earlier study. The results confirm some of our previous findings: (a) plasma CPZ levels vary widely among patients and correlate poorly with daily doses of CPZ; (b) increased plasma PRL is associated with higher plasma CPZ levels and is more common among the patients who develop EPS; and (c) none of these three variables differ between groups of patients with good and poor treatment outcome. However we did not confirm our previous finding of a significant association between EPS and higher plasma CPZ, nor did we find that the ratio of CPZ-sulphoxide to CPZ differed between the improved patients and the rest.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011388 Prolactin A lactogenic hormone secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). It is a polypeptide of approximately 23 kD. Besides its major action on lactation, in some species prolactin exerts effects on reproduction, maternal behavior, fat metabolism, immunomodulation and osmoregulation. Prolactin receptors are present in the mammary gland, hypothalamus, liver, ovary, testis, and prostate. Lactogenic Hormone, Pituitary,Mammotropic Hormone, Pituitary,Mammotropin,PRL (Prolactin),Hormone, Pituitary Lactogenic,Hormone, Pituitary Mammotropic,Pituitary Lactogenic Hormone,Pituitary Mammotropic Hormone
D011618 Psychotic Disorders Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994) Psychoses,Psychosis, Brief Reactive,Schizoaffective Disorder,Schizophreniform Disorders,Psychosis,Brief Reactive Psychoses,Brief Reactive Psychosis,Disorder, Psychotic,Disorder, Schizoaffective,Disorder, Schizophreniform,Disorders, Psychotic,Disorders, Schizoaffective,Disorders, Schizophreniform,Psychoses, Brief Reactive,Psychotic Disorder,Reactive Psychoses, Brief,Reactive Psychosis, Brief,Schizoaffective Disorders,Schizophreniform Disorder
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.
August 1976, Psychological medicine,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
August 1976, Psychopharmacology,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Effects of chlorpromazine on plasma prolactin and chlorpromazine levels [proceedings].
January 1977, Psychopharmacology bulletin,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Importance of akinesia: plasma chlorpromazine and prolactin levels.
November 1980, The American journal of psychiatry,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
May 1975, Psychological medicine,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Clinical response and plasma levels: effect of dose, dosage schedules, and drug interactions on plasma chlorpromazine levels.
June 1976, The American journal of psychiatry,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
October 1977, Acta psychiatrica Scandinavica,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Plasma prolactin levels during pregnancy.
September 1976, British journal of obstetrics and gynaecology,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Plasma levels of chlorpromazine and clinical response [proceedings].
January 1981, Psychopharmacology bulletin,
T Kolakowska, and M Orr, and M Gelder, and M Heggie, and D Wiles, and M Franklin
Plasma prolactin levels during a simulated dive.
July 1976, British medical journal,
Copied contents to your clipboard!